Table 5.
Treatment-Emergent Adverse Events Overall and by MedDRA Preferred Term in Subjects With Elevated Triglycerides and LDL-C (Multiple Ascending Dose Study, IV doses)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.